CysBio

CysBio

A company using metabolic engineering and synthetic biology to produce biochemicals from renewable feedstocks.

CysBio is a company using metabolic engineering and synthetic biology to produce biochemicals from renewable feedstocks that is headquartered in Kongens Lyngby, Denmark and was founded in 2019 by Henrik Meyer. The company is developing amino acids for food, feed and pharma; precursors for functional polymers and novel materials; the ability to modify pharmaceutical compounds to increase solubility and bioavailability; and biodegradable antifouling agents.

Funding

Seed

On March 22, 2019 CysBio completed their seed funding round with ~$6 million in funding from Zhejiang NHU. The company also announced it has reached a partnership agreement with Zhjiang NHU at the time of receiving seed funding. The partnership is meant to speed up how fast CysBio can bring their first product to market by leveraging the ability of Zhejiang to help scale up the manufacturing and sale of CysBio products. The companies publically stated they plan on bringing their first product to market at some time in 2020.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
CysBio funding round, March 22, 2019
Seed round
6,000,000
March 22, 2019
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.